Resultados da pesquisa - Christopher J. Logothetis

Refinar resultados
  1. 1
    Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors

    Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors Por John C. Araujo, Christopher J. Logothetis

    Publicado em 2010
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    The management of brain metastases in germ cell tumors

    The management of brain metastases in germ cell tumors Por Christopher J. Logothetis, Melvin L. Samuels, Antonio Trindade

    Publicado em 1982
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes

    Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes Por Ana M. Aparicio, Christopher J. Logothetis, Sankar N. Maity

    Publicado em 2011
    Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  4. 4
    Brain metastasis from prostate carcinoma

    Brain metastasis from prostate carcinoma Por Ian E. McCutcheon, David Y. Eng, Christopher J. Logothetis

    Publicado em 1999
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    The growing teratoma syndrome

    The growing teratoma syndrome Por Christopher J. Logothetis, Melvin L. Samuels, Antonio Trindade, Douglas E. Johnson

    Publicado em 1982
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer

    Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer Por Farshid Dayyani, Gary E. Gallick, Christopher J. Logothetis, Paul G. Corn

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  7. 7
    Current perspectives on bone metastases in castrate-resistant prostate cancer

    Current perspectives on bone metastases in castrate-resistant prostate cancer Por Christopher J. Logothetis, Michael J. Morris, Robert B. Den, Robert E. Coleman

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  8. 8
    The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials

    The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials Por Andreas Varkaris, Paul G. Corn, Sanchaika Gaur, Farshid Dayyani, Christopher J. Logothetis, Gary E. Gallick

    Publicado em 2011
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  9. 9
    Genes with a large intronic burden show greater evolutionary conservation on the protein level

    Genes with a large intronic burden show greater evolutionary conservation on the protein level Por Olga Y. Gorlova, A. N. Fedorov, Christopher J. Logothetis, Christopher I. Amos, Ivan P. Gorlov

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Combinatorial Screenings in Patients

    Combinatorial Screenings in Patients Por Amado J. Zurita, Patricia Troncoso, Marina Cardó‐Vila, Christopher J. Logothetis, Renata Pasqualini, Wadih Arap

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Adipose tissue‐derived stem cells promote prostate tumor growth

    Adipose tissue‐derived stem cells promote prostate tumor growth Por Lukas Prantl, Fabian Muehlberg, Nora M. Navone, Yao‐Hua Song, Jody V. Vykoukal, Christopher J. Logothetis, Eckhard Alt

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Adaptive Therapy for Androgen-Independent Prostate Cancer: A Randomized Selection Trial of Four Regimens

    Adaptive Therapy for Androgen-Independent Prostate Cancer: A Randomized Selection Trial of Four Regimens Por P. Thall, Christopher J. Logothetis, Lance C. Pagliaro, Sijin Wen, Matthew A. Brown, Dallas Williams, R. E. Millikan

    Publicado em 2007
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Molecular Classification of Prostate Cancer Progression: Foundation for Marker-Driven Treatment of Prostate Cancer

    Molecular Classification of Prostate Cancer Progression: Foundation for Marker-Driven Treatment of Prostate Cancer Por Christopher J. Logothetis, Gary E. Gallick, Sankar N. Maity, Jeri Kim, Ana M. Aparicio, Eleni Efstathiou, Sue-Hwa Lin

    Publicado em 2013
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  14. 14
    Phase III Trial of Androgen Ablation With or Without Three Cycles of Systemic Chemotherapy for Advanced Prostate Cancer

    Phase III Trial of Androgen Ablation With or Without Three Cycles of Systemic Chemotherapy for Advanced Prostate Cancer Por Randall E. Millikan, Sijin Wen, Lance C. Pagliaro, Melissa A. Brown, Brenda Moomey, Kim‐Anh Do, Christopher J. Logothetis

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    CTLA-4 blockade increases IFNγ-producing CD4 <sup>+</sup> ICOS <sup>hi</sup> cells to shift the ratio of effector to regulatory T cells in cancer patients

    CTLA-4 blockade increases IFNγ-producing CD4 <sup>+</sup> ICOS <sup>hi</sup> cells to shift the ratio of effector to regulatory T cells in cancer patients Por Chrysoula I. Liakou, Ashish M. Kamat, Derek Ng Tang, Hong Chen, Jingjing Sun, Patricia Troncoso, Christopher J. Logothetis, Padmanee Sharma

    Publicado em 2008
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Posttranslational regulation of Akt in human cancer

    Posttranslational regulation of Akt in human cancer Por Chia‐Hsin Chan, Ukhyun Jo, Abraham Q. Kohrman, Abdol Hossein Rezaeian, Ping-Chieh Chou, Christopher J. Logothetis, Hui‐Kuan Lin

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  17. 17
    Ligand‐independent activation of MET through IGF‐1/IGF‐1R signaling

    Ligand‐independent activation of MET through IGF‐1/IGF‐1R signaling Por Andreas Varkaris, Sanchaika Gaur, Nila U. Parikh, Jian H. Song, Farshid Dayyani, Jung‐Kang Jin, Christopher J. Logothetis, Gary E. Gallick

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases

    Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases Por David J. Grignon, Jae Y. Ro, Alberto G. Ayala, David T. Shum, Nelson G. Ordóǹez, Christopher J. Logothetis, Douglas E. Johnson, Bruce Mackay

    Publicado em 1992
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Identification of Cell Cycle Regulatory Genes as Principal Targets of p53-mediated Transcriptional Repression

    Identification of Cell Cycle Regulatory Genes as Principal Targets of p53-mediated Transcriptional Repression Por Kevin B. Spurgers, David Gold, Kevin R. Coombes, Nicole L. Bohnenstiehl, Brian Mullins, Raymond E. Meyn, Christopher J. Logothetis, Timothy J. McDonnell

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    A Secreted Isoform of ErbB3 Promotes Osteonectin Expression in Bone and Enhances the Invasiveness of Prostate Cancer Cells

    A Secreted Isoform of ErbB3 Promotes Osteonectin Expression in Bone and Enhances the Invasiveness of Prostate Cancer Cells Por Nanyue Chen, Xiang-cang Ye, Khoi Chu, Nora M. Navone, E. Helene Sage, Li‐Yuan Yu‐Lee, Christopher J. Logothetis, Sue-Hwa Lin

    Publicado em 2007
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: